FindTrial
Sign In

A Prospective Randomized Study:Comparing Rezum Therapy versus Bipolar Transurethral Enucleation of the Prostate for Treating older Benign Prostatic Hyperplasia

A Prospective Randomized Study:Comparing Rezum Therapy versus Bipolar Transurethral Enucleation of the Prostate for Treating older Benign Prostatic Hyperplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090503
Enrollment
Unknown
Registered
2024-10-07
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Experimental group (REZUM) :REZUM operation
Control group (TUEP):Enucleation of the prostate(TUEP)

Sponsors

Pingxiang People Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: No obvious abnormality in coagulation function, platelet count greater than 50×109, heart function = grade 3, pulmonary function: normal lung function or mild to moderate ventilatory dysfunction, no obvious abnormality in liver and kidney function

Exclusion criteria

Exclusion criteria: Heart function level 4, coagulation function PT>18s, pulmonary function: severe or above ventilatory dysfunction.

Design outcomes

Primary

MeasureTime frame
International Prostate Symptom Score(IPSS);Quality of life score(QoF);Operation time;—

Secondary

MeasureTime frame
Operation complication;The volume of bleeding;Length of stay and cost;—

Countries

China

Contacts

Public ContactYan Haichen

Pingxiang People Hospital

haichenyan.surgery@gmail.com+86 136 3594 8122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026